Advanced Search

Publications > Journals > Cancer Screening and Prevention > About the journal

About the journal
Aims and Scope

Cancer Screening and Prevention (CSP) publishes high-quality research and review articles related to cancer screening and prevention. It aims to provide a platform for studies that develop innovative and creative strategies and precise models for screening, early detection, and prevention of various cancers. Studies on the integration of precision cancer prevention multiomics where cancer screening, early detection and prevention regimens can precisely reflect the risk of cancer from dissected genomic and environmental parameters are particularly welcome.

Specifically, CSP publishes epidemiological, translational, and clinical studies on screening, early diagnosis, prevention of various cancers, especially gastrointestinal cancers. Topics of particular interest include but are not limited to:

  • Epidemiology of cancers
  • New strategies or models
  • Novel discoveries of biomarkers
  • Novel devices and clinical application
  • Innovative techniques and clinical application
  • Novel theories and mechanisms
  • Evidence-based medicine
  • Early detection of cancer
  • Precision cancer screening and prevention
  • Future perspectives

The acceptable categories include original article, review article, systematic review, meta-analysis, short communication, letter to the editor, and invited editorial & commentaries on rapidly progressing areas within the scope. All articles published by CSP, both solicited and unsolicited, must have passed a rigorous peer review.

Open Access

Cancer Screening and Prevention (CSP) adopts open access publishing model, and all articles are distributed under the terms of the CC BY-NC 4.0 license (http://creativecommons.org/licenses/by-nc/4.0/). Under this license, anyone may copy, distribute, or reuse these articles for non-commercial purposes, provided the original work is properly cited. Manuscripts submitted for publication in an open access journal are subject to the same rigorous peer-review and quality control as in scholarly subscription journals.

CSP recognizes the distinct advantages of using an open access publication model to timely disseminate innovative and important research findings. Unrestricted free access to our publications is anticipated to foster intellectual discourse across geographic and disciplinary boundaries. To support the success of our open access approach, we ensure the integrity and high quality of research published in our journal by practicing a rigorous peer review process and by following strict guidelines for ethics in publication and in conduct of the scientific process.

Publication Criteria

All manuscripts submitted to CSP must meet the following criteria for publication:

  • Topics with timely relevance to the general field or specialties in basic and clinical medicine;
  • Results and findings that have not been previously published elsewhere;
  • Research performed with adherence to accepted global standards for ethics in the scientific process;
  • Ethical reporting of data to protect the rights and privacy of study participants;
  • Appropriate statistical analyses, with sufficient descriptions of all statistical methods used;
  • Conclusions supported by the data presented;
  • All funding sources and their roles cited;
  • For clinical trials, the registration number cited;
  • Manuscript written in standard American (US) English and formatted according to the journal-specific guidelines;
  • No instances of textual plagiarism, including ‘text recycling/self-plagiarism”.
Publishing Schedule
CSP currently publishes 4 issues a year, in March, June, September and December.
Indexing Services
Journal Metrics
CSP Metrics (2023)
Acceptance rate: 44% 
Median time from submission to first decision: 18 days 
Median time from acceptance to online publishing: 17 days
Revenue Sources

CSP adopts the open access publishing model. Revenues are generated from article processing charges, permission fees, and reprints.

CSP is owned and published by Xia & He Publishing Inc.
Contact us
Editorial Office

Managing Editor: Lisa Chen
Postal Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA


Xia & He Publishing Inc.
Tel: +1-409-420-2868 

US Office
Address: 14090 Southwest Freeway, Suite 300, Sugar Land, Texas 77478, USA

China Office
Address: Room 505, Building B1, Bio-innovation Park, No. 666 High-tech Road, East Lake High-tech Development Zone, Wuhan, China
Back to Top